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Abstract 
The risks associated with gestational diabetes (GD) can be reduced with an active treatment able to improve glycemic control. 
Advances in mobile health can provide new patient-centric models for GD to create personalized health care services, 
increase patient independence and improve patients' self-management capabilities, and potentially improve their treatment 
compliance. In these models, decision-support functions play an essential role. The telemedicine system MobiGuide provides 
personalized medical decision support for GD patients that is based on computerized clinical guidelines and adapted to a 
mobile environment. The patient's access to the system is supported by a smartphone-based application that enhances the 
efficiency and ease of use of the system. We formalized the GD guideline into a computer-interpretable guideline (CIG). 
We identified several workflows that provide decision-support functionalities to patients and 4 types of personalized advice 
to be delivered through a mobile application at home, which is a preliminary step to providing decision-support tools in 
a telemedicine system: (I) therapy, to help patients to comply with medical prescriptions; (2) monitoring, to help patients 
to comply with monitoring instructions; (3) clinical assessment, to inform patients about their health conditions; and (4) 
upcoming events, to deal with patients' personal context or special events. The whole process to specify patient-oriented 
decision support functionalities ensures that it is based on the knowledge contained in the GD clinical guideline and thus 
follows evidence-based recommendations but at the same time is patient-oriented, which could enhance clinical outcomes 
and patients' acceptance of the whole system. 
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Gestational diabetes (GD) is defined as any degree of glu-
cose intolerance with onset or first recognition during preg-
nancy.1 It is a prevalent condition present in 7% (ranging 
from 1% to 14%) of pregnancies.2 Several adverse outcomes 
are associated with GD, as cesarean section, shoulder dysto-
cia, fetal macrosomia, neonatal respiratory problems, or 
metabolic complications. The risks of perinatal complica-
tions can be reduced with an active treatment, according to 
recent randomized control trials.3'4 
GD has long-term health impact, being the probability of 
developing GD in a subsequent pregnancy of the order of 
30% to 50%>.5 Women with GD are at an increased later risk 
of type 2 diabetes, as high as 50%o within 5 years in some 
populations.6 
Telemedicine systems have been widely applied to diabe-
tes care, showing that they are able to improve clinical out-
comes and self-care by registering electronically diabetes 
monitoring data.7"11 In the field of pregnancy complicated 
with diabetes, telemedicine systems have shown that they are 
able to reduce the need for outpatient clinical encounters,12 
achieve better pregnancy outcomes,13 and enhance feelings 
of psychosocial self-efficacy.14 Telemedicine for GD can be 
complemented by knowledge management tools to aid doc-
tors with therapy planning.15 This type of decision-support 
system (DSS) could potentially contribute to enhance the 
general adoption of telemedicine systems for diabetes.16 
DSSs could support not only doctors, but also patients; 
advances in the area of mobile communication for health care 
(m-Health) allow the design and development of patient-cen-
tric models to create personalized telemedicine services, 
increase patient independence and improve patient's self-
management capabilities. Patients can benefit from the use of 
personal assistants based on portable devices and supported 
by a telemedicine platform.17 Mobile applications for people 
with diabetes allow using automatic processing tools to pro-
vide real-time advice based on monitoring data and expert 
feedback,18 have a motivational effect on the users,19 and 
show important benefits when providing feedback to patients 
about blood glucose (BG) monitoring.20 In addition, mobile 
technologies are well accepted by patients with diabetes.21 
DSSs can base their knowledge on clinical practice guide-
lines (CPGs). CPGs provide recommendations on the appro-
priate treatment and care of people with a specific disease 
and conditions, and they are based on a systematic review of 
clinical evidence. Even though the use of mobile systems to 
support self-management of diabetes is widely extended, 
there are gaps between the evidence-based recommendations 
in CPGs and the functionality used in study interventions or 
found in online markets, which could limit the obtained ben-
efits and final outcomes.22 
This article describes the process based on CPGs to 
extract personalized decision support for patients with GD, 
which will be delivered anytime everywhere, supported by a 
telemedicine system for patient guidance (MobiGuide).23 
The MobiGuide services are based on computer-interpreta-
ble guidelines (CIGs): formal representations of CPGs that 
can be executed to provide guideline-based decision support 
specific to patient's data. 
The next sections describe the main components of 
MobiGuide, the methodology to elicit decision-support func-
tionalities addressed to patients based on the GD clinical 
guideline, the components of the smartphone application, the 
formalization of the guideline into workflows, and patient-
oriented advice to be generated in MobiGuide. 
Methods 
The MobiGuide Patient Guidance System 
The MobiGuide system aims to help patients to manage their 
illness by monitoring disease parameters and providing, in a 
mobile environment, the appropriate feedback generated on 
the basis of the patients' preferences (eg, meal times) and 
context (eg, routine vs semiroutine meal schedule). 
The main components of MobiGuide system are (1) a 
back-end DSS, devoted to the representation and execution 
of CIGs, which projects parts of the knowledge to a comple-
mentary mobile DSS (mDSS) that supports the distribution 
of decision support; (2) a body area network (BAN) that 
provides real-time monitoring of biosignals supported by a 
smartphone application that communicates with the back-
end server and manages the communications between differ-
ent components in the smartphone (eg, QoD, mDSS) and 
provides authentication policies; (3) a personal health record 
(PHR) that is ubiquitously and securely accessible and inte-
grates patients' personal data with data from hospital elec-
tronic medical records (EMRs) and the BAN data sources; 
and (4) a knowledge base containing CIGs. The DSS matches 
the CIG knowledge with PHR data to deliver CPG-based 
recommendations. GD is 1 of the target clinical domains to 
test the MobiGuide system and its clinical effectiveness in a 
clinical pilot. 
The Smartphone User Interface (ill) 
The goal of the smartphone UI, which can be run in Android 
devices from version 2.x, is to enhance the efficiency and 
ease of use for the underlying logical design of the system. 
The mobile application is the patient's interface to the 
MobiGuide system, allowing reception of patient guidance 
services supported by the CIG-based DSS. The UI provides 
functions to configure guidance through patient's personal 
context selection and to receive personalized recommenda-
tions based on CPGs. The UI for GD patients allows manual 
data insertion, automatic acquisition from sensors (Bluetooth-
enabled glucometer and blood pressure monitor and smart-
phone's accelerometer) and visualization of monitoring data 
including BG measurements, diet incompliance, ketonuria 
results, insulin administration (when required), and physical 
activity sessions. 
The smartphone UI has been designed following a modu-
lar approach based on the model-view-controller architec-
ture. Figure 1 shows its internal structure, detailing the logic 
interactions amongst the functional modules of the smart-
phone UI, as well as the interactions between the UI and the 
rest of the mobile components of MobiGuide system (for 
clarity, Figure 1 does not reflect the interactions between the 
rest of components inside the smartphone). 
• Views: The different graphical elements and screens 
oftheUI. 
• Authentication: Manages BAN activation and user 
authentication and authorization information. 
• Data Controller: Manages application data (monitoring 
data inserted by the patient or to be visualized), context 
data, configuration data, and recommendations. 
• Secure Storage Controller: Deals with the secure stor-
age of all configuration and personalization data. 
• Messaging: Manages the message exchange with 
other components of the system (the quality of data 
(QoD) service provided by the QoD broker, which 
impacts decision making) and the mDSS, which pro-
vides patient-tailored recommendations based on CIG 
knowledge projected from the back-end DSS. 
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Figure I. Internal structure of the smartphone user interface. 
• BANServiceConnection: Interface between the smart-
phone UI and the BAN, facilitating all the BAN ser-
vices that can be used by the GD application (including 
the methods to control its lifecycle). 
• QoDServiceConnection and mDssServiceConnec-
tion: The smartphone UI uses these interfaces to 
access mDSS and QoD broker lifecycle control 
methods. 
• Mobile Lifecycle Controller. Mobile components' 
lifecycle choreographer. 
Specification of Patient-oriented Decision Support 
From CPGs 
The methodology to extract patient-oriented knowledge from 
CPGs has 3 steps. The first 2 are based on part of the knowl-
edge acquisition and specification process, which has been 
previously developed and evaluated for the specification of 
CPGs by expert physicians and knowledge engineers.24'25 
Selection ofGD Guideline. Since 2005, several evidence-based 
guidelines have been published on diabetes in pregnancy1'26 
and new diagnostic criteria and their implications needed to 
be considered. So, a local narrative consensus-guideline for 
GD was generated by expert endocrinologists of Hospital de 
Sabadell based on the previously published documents. 
Specification of the Local Consensus. The GD local narrative 
consensus-guideline was analyzed and the main procedures 
involved in GD management were identified. We iteratively 
developed a semiformal graphical representation of the CPG 
to produce consensus workflows specifying just the parts of 
the CPG that would be within the scope of the telemedicine 
system, free from ambiguity and accepted by the knowledge 
engineers and medical experts, considering both explicit and 
implicit medical knowledge necessary to provide decision 
support. 
Because the DSS provides advice to patients, in addition 
to care providers, we have formalized the GD guideline in 2 
parallel workflows.28 Creating the patient's workflow 
involved identifying those recommendations that would 
imply advice for the patient, typically to be carried out at 
home (eg, to measure BG). Another extension of the original 
knowledge acquisition method involved determining how 
decision-support functionalities should be distributed 
between the back-end DSS and mDSS. 
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A novel step added to the knowledge acquisition process 
included customization. 
Customization. We elaborated the specification of the GD 
guideline with customization of the CIGs to address patient's 
personal context (eg, reduce number of BG measurements 
during periods of semiroutine meal schedules) and the sys-
tem's technological context (eg, when the battery is low, del-
egate processing to different system components), as well as 
allow personalization based on local preferences (eg, send-
ing reminders at patient-specific meal times). 
Results 
Formalization of Gestational Diabetes Guideline 
for the Telemedicine System 
The analysis and formalization of the GD local guideline 
consensus, performed by knowledge engineers in consulta-
tion with experts of Hospital de Sabadell, was carried out in 
10 iterations. The contents were formalized as a top-level 
workflow of the GD management process and more specific 
workflows for each of its main processes. 
Figure 2 shows the main workflows identified in GD. We 
scoped the care process to be supported by the MobiGuide 
system to start after the diagnosis of GD. To initialize the 
system with preexisting conditions, it is required to acquire a 
set of minimum clinical parameters, such as clinical history, 
health state, current treatment, and so on. After GD is con-
firmed by the endocrinologist, the patient can be enrolled 
into the MobiGuide system, and 2 different workflows are 
activated: (1) Monitoring variables involved in the manage-
ment of GD, including monitoring clinical parameters such 
as BG, ketonuria, or relevant obstetrical parameters and 
monitoring the patient's compliance with the prescribed 
treatment; and (2) Therapy, which can be related to nutri-
tional, exercise, or insulin prescription. The dismissal of the 
patient from the MobiGuide system will be done when GD is 
not present, which usually happens after delivery of the baby. 
As an example of patient-tailored advice extracted from 
the GD guideline, Figure 3 shows a simplified version of the 
workflow for BG Monitoring. We consider 2 different work-
flows to establish the conditions that would generate patient 
advice, for a specific patient: (1) check frequency of moni-
toring BG and (2) check glycemic control (ie, BG level). It 
is important to assess the patient's compliance to (1) moni-
toring instructions or to (2) nutritional prescription, as 
checking compliance is usually done by clinicians during 
clinical encounters while here it is done by the MobiGuide 
system. 
The formalization of each care process defines 2 parallel 
workflows: one to support patients and the other for provid-
ing decision support to clinicians. As in Figure 3, regarding 
BG monitoring, clinicians would receive recommendations 
to reinforce the patient's education when the system detects 
that the patient is repeatedly not being compliant to nutri-
tional prescription. Also, clinicians will get recommenda-
tions to change the current prescription regarding diet, 
exercise, and/or insulin when it is detected that glycemic 
control is not achieved. 
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Extraction of Patient-oriented Advice 
After creating the local consensus of the GD guideline as a 
set of parallel workflows, we identified 4 different types of 
advice addressed to patients (Figure 4): 
Therapy Advice. The aim of therapy advice is to help the 
patient to comply with medical prescription. Two different 
types of advice are identified: 
Messages to acknowledge or to reinforce the patient's com-
pliance with therapy prescriptions. Patients with GD are 
responsible for following therapy prescriptions at home. The 
workflows related to "monitor diet compliance" and "moni-
tor exercise compliance" will control the patient's adherence 
to clinicians' recommendations. In addition, if the patient 
needs to administer insulin, the workflow "monitor insulin 
compliance" will be used. Monitoring diet or insulin com-
pliance will allow establishing the cause and effect relation-
ship between prescribed therapy (diet or insulin) and BG 
level. As in Figure 5, the system will ask the patient about 
diet compliance when anomalous BG levels are detected. On 
the contrary, when the patient shows good compliance with 
therapy prescription, she or he will receive feedback from the 
system to reinforce her or his motivation while managing the 
disease (Figure 5). 
Reminders to follow therapy prescription related to insulin 
administration. This type of advice will be generated accord-
ing to a personalized schedule of the patient. The patient may 
choose to get reminders for all of her or his daily injections or 
just specific ones. 
Monitoring Advice. The aim of monitoring advice is to help 
the patient comply with monitoring instructions. Two differ-
ent types of advice are identified: 
Reminders to monitor specific parameters such as BG, exer-
cise, or ketonuria (Figure 3, Remind monitoring). In MobiGuide, 
physical activity practicing and its intensity is detected auto-
matically with a physical activity detector. Reminders will be 
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Figure 4. Classification of patient advice extracted from the gestational diabetes guideline formalization. 
generated for those patients who activate this functionality, 
according to the personalized schedule. 
Messages to acknowledge or reinforce the patient's compli-
ance with monitoring parameters. When the patient does not 
perform measurements frequently enough or when she is 
not downloading data to the system so that data can be ana-
lyzed according to periodic requirements, the patient will be 
warned. If the situation persists, the patient could be asked 
to attend an on-site visit, after notifying the clinician (Figure 
3, Reinforce compliance). On the contrary, if the patient is 
following monitoring instructions appropriately, she or he 
will receive periodic congratulations messages to keep her 
or him motivated (Figure 3, Acknowledge compliance). 
Clinical Assessment Advice. The aim of clinical assessment 
advice is to inform patients about the assessment of GD con-
ditions, generally reflected by monitoring parameters such as 
BG or ketonuria. We identified 2 types of advice: 
Messages to inform that a therapy change is needed after the 
analysis of current monitoring parameter values (Figure 3, Visit 
to change therapy). Some of these messages (such as diet or 
insulin therapy changes) should be confirmed by clinicians 
before they are delivered to patients. 
Messages asking patients to contact the hospital. Some con-
ditions detected by the telemedicine system could require 
a physical encounter at the hospital, such as a session to 
reinforce education when the patient is not being compliant 
repeatedly (Figure 3, Visit to reinforce education) or when it 
is required to start insulin treatment. 
Upcoming event advice. The aim of these advice is to help 
modulating the patient's monitoring instructions or ther-
apy follow-up, according to personal context or sporadic 
events. The advice are related to personal context situa-
tions when the diet, physical activity, or monitoring sched-
ule of the patient may not be routine, as in an upcoming 
holiday. These events would cause the generation of 
reminders or specific messages, once physicians relate 
patient-specific events to personal contexts in the custom-
ized CIGs. The context of the messages could be precon-
figured by the physician. 
Patients too have a role in personalizing advice. Patients 
can personalize their preferred time to perform physical 
activity and its intensity level or duration, depending on their 
personal context. For example, if the patients are traveling, 
they can activate their "semiroutine meal schedule" context 
and then will not receive alerts about low compliance to 
physical activity recommendations. 
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Figure 5. Example of therapy advice delivered to the patient: (A) Congratulations message to acknowledge good compliance and advice 
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Discussion 
Patients with GD need to acquire the appropriate knowl-
edge about the disease in a relatively short period of time 
(in most cases from diagnosis to delivery lower than 6 
months). And at the same time they need to manage com-
plex procedures at home, including monitoring of BG, esti-
mating proportions of carbohydrates for each meal, or, 
when required, administer insulin. On the other hand, these 
are generally very motivated patients as they are concerned 
with possible complications of the disease to the baby. 
A telemedicine patient guidance system such as 
MobiGuide can accompany the patient wherever she goes, 
helping to manage GD at anytime, through personalized 
advice according to the knowledge contained in the clinical 
guideline. The intelligent DSS analyzes historical clinical 
data, as it is connected to the PHR that integrates all relevant 
patient data, whether arriving from the hospital EMRs, BAN 
sensors, or entered manually by the patient (on her or his 
own initiative or when requested by the DSS). 
CIGs have been traditionally used to support clinicians' 
decision making processes, by developing DSS able to auto-
matically generate patient-specific recommendations at the 
point of care. So those recommendations related to "monitor-
ing" and "therapy" processes are directed toward care profes-
sionals who can explain them to their patients, but they are not 
actually applied in a functional automatic manner by a DSS. In 
this work, we formalized the knowledge from the GD guide-
line to generate patient-oriented decision support in a patient-
centric approach. The formalization included identifying those 
recommendations that could imply advice that is delivered by 
the system to the patient and in that way constitutes the start-
ing point of a process of care that is parallel to the CPG and 
can be executed by the patient's smartphone. 
We have extracted 4 different types of advice from the 
GD guideline. Some of these recommendations will require 
approval from the clinician before being sent to the patient 
(eg, a therapy change). But other advice (eg, medication 
and measurement reminders and positive compliance feed-
back) can be applied independently of clinicians, which 
will contribute to minimizing the workload of clinicians 
because the system can assess the patients' compliance to 
monitoring instructions or to therapy prescription instead 
of them, and present these results to the clinicians during 
routine visits. 
Also, we extracted different types of reminders that will 
be available to each patient depending on her or his prefer-
ences. These reminders could be used to help the patient 
comply with monitoring instructions (eg, BG monitoring) or 
to remind her or him to administer insulin. This type of 
advice is considered optional to avoid excessive generation 
of advice that could overload the patient. However, balanc-
ing the right amount of reminders and feedback to the patient 
is a challenging issue that we still need to address. 
Conclusions 
This work presents a process, based on clinical guidelines, to 
extract the workflows that allow generating personalized 
decision support for patients with GD in the telemedicine 
patient guidance system. The formalization of the GD local 
consensus guideline as a CIG has allowed identifying 2 paral-
lel patient-centric processes: one for the patient, and the other 
for the clinician. These processes are continuously applied by 
the DSS to deliver patient-oriented advice via the patient's 
smartphone. Some of these advice consider the patient's per-
sonal context, such as different schedules along workdays or 
holidays or upcoming events, which could trigger reminders 
or modify the advice that are generally configured. 
The whole process followed to specify patient-oriented 
decision support functionalities assures that it follows evi-
dence-based recommendations collected during care pro-
cesses in GD, which could improve clinical outcomes and 
patient's acceptance of the entire system. 
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